from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2660c/-

LFCtreatmentdescriptionclass of inhibitor

-0.326

Amikacinug/mL Amikacintranslation

0.936

Cap5-10ug/mL Capreomycintranslation

0.436

Rox10-50 ug/mL Roxithromycintranslation

1.948

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.724

Rif0.2-5ug/mL Rifampicintranscription

0.079

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.183

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.663

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.912

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.112

Clofazimine10-13 ug/mL Clofaziminerespiration

0.478

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.087

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.112

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.042

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.434

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.684

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.943

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.650

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.083

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.083

Nigericin50 uM Nigericinrespiration

0.037

TRC10-150 ug/mL Triclosanrespiration

0.414

TRZ10-25 ug/mL Thioridazinerespiration

-0.738

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.068

menadione6-10 ug/mL Menadionerespiration

-0.339

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.059

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.055

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.084

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.874

NRP_1Non-replicating persistence stage 1dosRassociated

-0.142

Amp0.2mg/mL AmpicillincellWall

-0.090

Cephalexin20-100 ug/mL CephalexincellWall

1.116

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.296

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.033

EMB10-20 ug/mL EthambutolcellWall

1.348

Eta12-40 ug/mL EthionamidecellWall

0.678

INH0.2-0.4 ug/mL IsoniazidcellWall

0.288

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.374

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.518

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.545

BZA0.12 mg/mL BenzamidearomaticAmides

0.329

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.268

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.969

H2O24 mM hydrogen peroxideDNAdamaging

-1.886

Levo10 ug/mL LevofloxacinDNAdamaging

0.154

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.383

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.799

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.076

UVUV-irradiationDNAdamaging

-0.243

ARP41-4 ug/mL Antitubercular compound ARP4?

0.240

Antimycin12.5-50 ug/mL Antimycin A?

-1.081

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.297

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.156

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.668

PA8240.2-2 ug/mL PA-824?

0.497

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.195

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.090

Verapamil50 uM Verapamil?

-1.562

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.173

methoxatin10-20 ug/mL Methoxatin?